Skip to content

Medicine 2024 | CME, Evaluation, & Certificate of Completion

Agenda
Faculty
Sponsors

How to Obtain Certificate of Completion

To obtain your certficate of completion, simply fill out your online evaluation. After clicking "Submit" at the end of your evaluation, you will be redirected to a PDF of the certificate. You can then print out the certificate and fill in your information for your own records.

Evaluation

Accreditation Statement

CME Category 1: 6.5 Total

This activity has been planned and implemented in accordance with the accreditation requirements of the Washington State Medical Association through the joint providership of Providence Health Care and the Spokane County Medical Society. Providence Health Care is accredited by the WSMA to provide continuing medical education for physicians.

Providence Health Care designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 6.5 hours of Category 1 CME credit to satisfy the re-licensure requirements of the Washington State Medical Quality Assurance Commission.

Meeting Objectives

At the conclusion of this program participants will be able to:

Howard Frumkin, MD, Dr.P.H., FACP: Climate Change and the Physician: What We Need to Know, What We Need to Do

  • Name at least five health impacts of climate change.
  • Explain the medical benefits of hope and describe how to support hope in the context of climate change.
  • Describe at least three actions physicians can take to address the climate crisis.

Carol H. Wysham, MD: Practical Use of Continuous Glucose Monitoring

  • State benefits of continuous glucose monitoring in patients with type 1 and type 2 diabetes.
  • State the difference between Professional and Personal CGM.
  • Understand interpretation of CGM reports.

Katherine R. Tuttle, MD, FASN, FACP, FNKF: Therapeutic Transformation of Chronic Kidney Disease

  • Describe the scale, risks, causes and mechanisms of chronic kidney disease (CKD).
  • Define guideline directed medical therapies (GDMT) to reduce kidney and cardiovascular risks of CKD.
  • Discuss strategies to implement GDMT in persons with CKD.

Ken Cathcart, DO: Testosterone: Friend or Foe

  • Learn how to diagnose male hypogonadism.
  • Learn how to treat male hypogonadism.

Laura J. Spece, MD: COPD: Updates and Review for 2024

  • Understand the new changes to the Global Obstructive Lung Disease (GOLD) practice guideline for COPD for primary care settings
  • Be able to diagnose COPD using spirometry and understand the impact to patients of different racial groups from the changes in the 2023 American Thoracic Society (ATS) guideline for pulmonary function testing.
  • Be able to select evidence-based inhaled therapy for COPD to improve symptom control and reduce exacerbation frequency.
  • Increase confidence in prescribing therapy for tobacco cessation.
  • Select patients with COPD for whom home oxygen therapy is most likely to improve clinical outcomes.
  • Be able to select evidence-based inhaled therapy for COPD to improve symptom control and reduce exacerbation frequency.
  • Identify clinical scenarios when pulmonary referral and surgical therapies for emphysema may help patient outcomes.
  • Updates on steroid management for outpatient (mild) COPD exacerbations.

Silvia Russo, MD: Updates on Diagnosis and Management of Alzheimer’s Disease and Related Disorders

  • Review what the internist can do during regular clinic visits to correctly identify and direct patients with dementia and mild cognitive impairment.
  • Learn what tools a primary doctor can use to help better counsel the patient and appropriately manage their cognitive concerns.
  • Discuss what the future holds for dementia care and focus on Alzheimer’s disease biomarkers and controversies of new anti-amyloid drugs.

IM Resident Jessica Wahlgren, MD: Women’s Health Update – Rising Topics in 2024

  • Review the updated breast cancer screening guidelines and who needs supplemental screening.
  • Discuss a novel non-hormonal medication for treatment of vasomotor symptoms.
  • Discuss appropriate use of testosterone therapy for women during menopause.